Hosted on MSN1mon
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn). The ...
FiercePharma28d
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...
MM&M21d
Rx Rundown: Moderna, Sanofi, GSK and more
Bain Capital said it will buy Mitsubishi Chemical’s pharma business for $3.37 billion. Sanofi and CD&R signed an Opella share purchase agreement. Biogen partnered with Stoke Therapeutics on a drug for ...
The Financial Times17d
Bain Capital, Chemring and the big-bang theory of M&A leaks
Bain Capital’s reported move is interestingly timed for several reasons. First, Chemring has an AGM trading update on Wednesday. Second, the stock had been strong of late on the realisation that ...